<table border="1"><tr><th>Free name</th><td><ul><li>Raltegravir</li></ul></td></tr><tr><th>Other names</th><td><ul><li>N | -[2-[(4 | Z | )-4-([(4-Fluorophenyl)methylamino]-hydroxymethylides)-1-methyl-5,6-dioxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazol-2-carboxamide | N | -(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-6-oxo-1,6-dihydro-4-pyrimidincarboxamide | RAL | MK-0518</li></ul></td></tr><tr><th>Sum formula</th><td><ul><li>C | 20 | H | 21 | FN | 6 | O | 5</li></ul></td></tr><tr><th>ECHA-InfoCard</th><td><ul><li>100.124.631</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>54671008</li></ul></td></tr><tr><th>ChemSpider</th><td><ul><li>16445111</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB06817</li></ul></td></tr><tr><th>Wikidata</th><td><ul><li>Q421552</li></ul></td></tr><tr><th>ATC-Code</th><td><ul><li>J05 | AX08</li></ul></td></tr><tr><th>Class of active substances</th><td><ul><li>Virostatics</li></ul></td></tr><tr><th>Mechanism of action</th><td><ul><li>Integraseinhibitor</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>444.41 g·mol | −1</li></ul></td></tr><tr><th>solubility</th><td><ul><li>water soluble</li></ul></td></tr><tr><th>GHS hazard labelling | no GHS pictograms</th><td><ul><li>no GHS pictograms</li></ul></td></tr><tr><th>H- and P-sets</th><td><ul><li>H | no H-sets</li></ul></td></tr><tr><th>Toxicological data</th><td><ul><li>&gt; 2000 mg·kg | −1 | (LD | 50 |, mouse, oral)</li></ul></td></tr><tr><th>General</th><td><ul><li>French name | Raltegravir | Other names | N | -[2-[(4 | Z | )-4-([(4-Fluorophenyl)methylamino]-hydroxymethylides)-1-methyl-5,6-dioxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazol-2-carboxamide | N | -(4-Fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}-2-propanyl)-6-oxo-1,6-dihydro-4-pyrimidincarboxamide | RAL | MK-0518 | Sum formula | C | 20 | H</li></ul></td></tr><tr><th>External Identifiers/Databases</th><td><ul><li>CAS Number | 518048-05-0 | 871038-72-1 | (Raltegravir-Kalium) | ECHA InfoCard | 100.124.631 | PubChem | 54671008 | ChemSpider | 16445111 | DrugBank | DB06817 | Wikidata | Q421552 | CAS Number | 518048-05-0 | 871038-72-1 | (Raltegravir-Kalium) | ECHA InfoCard | 100.124.631 | PubChem | 54671008 | ChemSpider | 16445111 | DrugBank | DB06817 | Wikidata | Q421552 | CAS Number | 518048-05-0 | 871038-72-1 |</li></ul></td></tr><tr><th>Drug data</th><td><ul><li>ATC code | J05 | AX08 | active class | virostatic | active mechanism | integrated inhibitor</li></ul></td></tr><tr><th>Properties</th><td><ul><li>Molar mass | 444.41 g·mol | −1 | solubility | water soluble</li></ul></td></tr><tr><th>GHS hazard labelling</th><td><ul><li>no GHS pictograms</li></ul></td></tr><tr><th>Safety Notes</th><td><ul><li>Please note the exemption from labelling for medicines, medical products, cosmetics, food and feed | GHS hazard labelling | no GHS pictograms | H and P seats | H | no H seats | P | no P seats | Please note the exemption from labelling for medicines, medical products, cosmetics, food and feed | GHS hazard labelling | no GHS pictograms | no GHS pictograms | H and P seats | H | no H seats | P | no P seats | Please note the exemption from labelling for medicines, medical products, cosmetics, food and feed | no GHS pictograms | H and P seats | H | no H seats | P | no P</li></ul></td></tr></table>